MétaCan
Menu
← Back to cohort
Record W4396995018 · doi:10.1681/asn.20213210s1499a

Precision Medicine Approach Identifies Patients with IgA Nephropathy at Risk for Progression Using Endothelin Activation Signatures

2021· article· en· W4396995018 on OpenAlexaff
Viji Nair, Wenjun Ju, Sean Eddy, Marvin Gunawan, N. Eric Olson, Joyce Y. Wu, Jennifer H. Cox, Andrew J. King, Matthias Kretzler

Bibliographic record

VenueJournal of the American Society of Nephrology · 2021
Typearticle
Languageen
FieldMedicine
TopicRenal Diseases and Glomerulopathies
Canadian institutionsAcuitas Therapeutics (Canada)
Fundersnot available
KeywordsNephropathyEndothelin 1MedicineEndothelin receptorNephrologyPrecision medicineInternal medicineUrologyEndocrinologyPathologyDiabetes mellitus

Abstract

fetched live from OpenAlex

Background: IgA nephropathy (IgAN) is the most common glomerulonephritis globally, with up to 40% of patients at risk of progressing to ESKD. Endothelin (ET) A receptor activation results in mesangial cell (MC) activation, proteinuria, inflammation, and fibrosis, all considered hallmarks of IgAN progression, suggesting the potential for therapeutic benefit of ETA antagonists. The aim of our study was to identify intra-renal transcriptional signatures of ET-activation to stratify patients at high risk of IgAN progression Methods: We used two approaches to establish a transcriptional signature of ET-activation. First, using a targeted approach, an ET-activation network was generated using three publicly available datasets, produced a geneset of 60 transcripts to create an activity score which was assessed in kidney biopsy profiles in patients with IgAN (n= 25) from the European Renal cDNA Bank (ERCB). In addition, an ET-activation signature was also generated experimentally via RNAseq profiling of primary human MCs simulated with ET1 (4nM) +/- the selective ETA antagonist atrasentan (1nM, 25nM, n=3/group). Pairwise differential gene expression and gene set enrichment analysis (GSEA) was performed. Results: The targeted analysis showed that the ET-activity score correlated with increased proteinuria (r=0.42, p=0.05) and decreased eGFR (r=-0.47, p=0.02) in patients with IgAN. The transcript network showed enrichment in endothelial and mesangial cell clusters in renal single cell RNASeq profiles. Differential expression analysis identified the ET gene network was reversed by atrasentan in MCs (25nM, n=780 genes, q£0.05). GSEA in MCs revealed up-regulation of cell proliferation, inflammatory and fibrotic networks, with ET1 treatment, which were blocked by atrasentan. Conclusions: We generated an ET-activation score using a systems biology approach to stratify patients with IgAN. Intra-renal ET-activation signatures were associated with progression, providing additional support for the therapeutic potential of ETA receptor blockade in IgAN patients at high risk of progression. Ongoing work is focused on optimizing the signature, extending findings to additional cohorts and identifying mechanistic biomarkers Funding: Other NIH Support - Federal grant, Commercial Support - Chinook Therapeutics

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.293
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicRenal Diseases and Glomerulopathies→French-language works237,207→